STIs Part III: Gonorrhea and Chlamydia

The Centers for Disease Control and Prevention just updated guidelines for sexually transmitted infections (previously sexually transmitted diseases) for everything by HIV. In this multi-part series, host Geoff Wall will break down what’s new and what’s changing in practice.The GameChangerA 7-day course of doxycycline in the treatment of urogenital chlamydia is preferred and has been shown to be more efficacious compared to azithromycin. Ceftriaxone should be the treatment of choice for gonorrhea as there have been no “resistance”-related treatment failures identified in the United States at any anatomical site.  Show Segments00:00 – Introduction01:45 – STI Guidelines02:34 – Chlamydia 14:56 – Gonorrhea 28:57 – Closing RemarksHost Geoff Wall, PharmD., BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health All relevant financial relationships have been mitigated. References and Resources CDC Sexually Transmitted Infections Treatment Guidelines, 2021Redeem your CPE or CMECPE (Pharmacist)CME (Physicians) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)Pharmacists: Get a membershipPrescribers: Get a membership CE Information Learning Objectives Describe the treatment of Neisseria gonorrhea based on the 2021 recommendationsDiscuss pharmacotherapy options for patients with chlamydia with or without concomitant gonorrhea infections0.05 CEU/0.5 Hr UAN: 0107-0000-22-224-H01-P Initial release date: 06/062022 Expiration date: 06/06/2023 Additional CPE and CME details can be found here.Follow CEimpact on Social Media:LinkedInInstagram